Functional characterization of the Thr946Ala SNP at the type 1 diabetes IFIH1 locus

Autoimmunity

Volumn 47, Issue 1, 2014, Pages 40-45

  Zouk, Hana ^a,b   Marchand, Luc ^a   Li, Quan ^a   Polychronakos, Constantin ^a,b,c  

^a MONTREAL CHILDREN S HOSPITAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Coding polymorphism; ELISA; Poly I:C stimulation; Type I interferon production; Viral recognition receptor

Indexed keywords

ALPHA INTERFERON; CYTOKINE; POLYINOSINIC POLYCYTIDYLIC ACID;

ALLELE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE; GENE EXPRESSION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC TRANSFECTION; GENOTYPE; HUMAN; HUMAN CELL; IFIH1 GENE; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOBLASTOID CELL LINE; SINGLE NUCLEOTIDE POLYMORPHISM;

AMINO ACID SUBSTITUTION; CODON; DEAD-BOX RNA HELICASES; DIABETES MELLITUS, TYPE 1; GENOTYPE; HUMANS; INTERFERON-ALPHA; POLYMORPHISM, SINGLE NUCLEOTIDE; QUANTITATIVE TRAIT LOCI;

EID: 84891802663     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.3109/08916934.2013.832758     Document Type: Article

References (47)

1. Smyth, D. J., J. D. Cooper, R. Bailey, et al. 2006. A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region. Nat. Genet. 38:617-619. (Pubitemid 43927300)
2. Martinez, A., J. L. Santiago, M. C. Cenit, et al. 2008. IFIH1-GCAKCNH7 locus: influence on multiple sclerosis risk. Euro. J. Human Genet. EJHG 16:861-864. (Pubitemid 351865684)
3. Martinez, A., J. Varade, J. R. Lamas, et al. 2008. Association of the IFIH1-GCA-KCNH7 chromosomal region with rheumatoid arthritis. Ann. Rheum. Dis. 67:137-138.
4. Cunninghame Graham, D. S., D. L. Morris, T. R. Bhangale, et al. 2011. Association of NCF2, IKZF1, IRF8, IFIH1, and TYK2 with systemic lupus erythematosus. PLoS Genet. 7:e1002341.
5. Sutherland, A., J. Davies, C. J. Owen, et al. 2007. Genomic polymorphism at the interferon-induced helicase (IFIH1) locus contributes to Graves' disease susceptibility. J. Clin. Endocrinol. Metab. 92:3338-3341. (Pubitemid 47236412)
6. Concannon, P., S. Onengut-Gumuscu, J. A. Todd, et al. 2008. A human type 1 diabetes susceptibility locus maps to chromosome 21q22.3. Diabetes 57:2858-2861.
7. Liu, S., H. Wang, Y. Jin, R. Podolsky, et al. 2009. IFIH1 polymorphisms are significantly associated with type 1 diabetes and IFIH1 gene expression in peripheral blood mononuclear cells. Hum. Mol. Genet. 18:358-365.
8. Nejentsev, S., N. Walker, D. Riches, et al. 2009. Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. Science 324:387-389.
9. Qu, H. Q., L. Marchand, R. Grabs, and C. Polychronakos. 2008. The association between the IFIH1 locus and type 1 diabetes. Diabetologia 51:473-475.
10. Todd, J. A., N. M. Walker, J. D. Cooper, et al. 2007. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat. Genet. 39:857-864. (Pubitemid 47018195)
11. Ng, P. C., and S. Henikoff. 2003. SIFT: predicting amino acid changes that affect protein function. Nucl. Acids Res. 31: 3812-3814. (Pubitemid 37442253)
12. Sunyaev, S., V. Ramensky, I. Koch, et al. 2001. Prediction of deleterious human alleles. Hum. Mol. Genet. 10:591-597. (Pubitemid 32229363)
13. Kang, D. C., R. V. Gopalkrishnan, Q. Wu, et al. 2002. mda-5: an interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties. Proc. Natl. Acad. Sci. USA 99:637-642. (Pubitemid 34106564)
14. Kang, D. C., R. V. Gopalkrishnan, L. Lin, et al. 2004. Expression analysis and genomic characterization of human melanoma differentiation associated gene-5, mda-5: a novel type I interferonresponsive apoptosis-inducing gene. Oncogene 23:1789-1800. (Pubitemid 38445170)
15. Yoneyama, M., M. Kikuchi, K. Matsumoto, et al. 2005. Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J. Immunol. 175: 2851-2858. (Pubitemid 41170502)
16. Honda, K., H. Yanai, H. Negishi, et al. 2005. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434:772-777. (Pubitemid 44739521)
17. Barral, P. M., J. M. Morrison, J. Drahos, et al. 2007. MDA-5 is cleaved in poliovirus-infected cells. J. Virol. 81:3677-3684. (Pubitemid 46586864)
18. Kato, H., O. Takeuchi, S. Sato, et al. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441:101-105.
19. Gitlin, L., W. Barchet, S. Gilfillan, et al. 2006. Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc. Natl. Acad. Sci. USA 103:8459-8464. (Pubitemid 43838477)
20. Loo, Y. M., J. Fornek, N. Crochet, et al. 2008. Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J. Virol. 82: 335-345. (Pubitemid 350309149)
21. Devendra, D., and G. S. Eisenbarth. 2004. Interferon alpha-a potential link in the pathogenesis of viral-induced type 1 diabetes and autoimmunity. Clin. Immunol. 111: 225-233. (Pubitemid 38739316)
22. Devendra, D., J. Jasinski, E. Melanitou, et al. 2005. Interferon-alpha as a mediator of polyinosinic:polycytidylic acid-induced type 1 diabetes. Diabetes 54: 2549-2556. (Pubitemid 41233575)
23. Moriyama, H., L. Wen, N. Abiru, et al. 2002. Induction and acceleration of insulitis/diabetes in mice with a viral mimic (polyinosinic-polycytidylic acid) and an insulin self-peptide. Proc. Natl. Acad. Sci. USA 99: 5539-5544. (Pubitemid 34411584)
24. Sobel, D. O., J. Newsome, C. H. Ewel, et al. 1992. Poly I:C induces development of diabetes mellitus in BB rat. Diabetes 41: 515-520.
25. Nakamura, N., Y. Tsutsumi, S. Kimata, et al. 1991. Induction of diabetes by PolyI:C and anti-RT6.1 antibody treatment in DR-BB rats. Endocrinol. Jpn. 38: 523-526.
26. Varela-Calvino, R., and M. Peakman. 2003. Enteroviruses and type 1 diabetes. Diabetes Metab. Res. Rev. 19: 431-441. (Pubitemid 37536960)
27. Hyoty, H., and K. W. Taylor. 2002. The role of viruses in human diabetes. Diabetologia 45: 1353-1361. (Pubitemid 35244887)
28. Roivainen, M. 2006. Enteroviruses: new findings on the role of enteroviruses in type 1 diabetes. Int. J. Biochem. Cell Biol. 38: 721-725. (Pubitemid 43363408)
29. van der Werf, N., F. G. Kroese, J. Rozing, and J. L. Hillebrands. 2007. Viral infections as potential triggers of type 1 diabetes. Diabetes Metab. Res. Rev. 23: 169-183. (Pubitemid 46437842)
30. Ylipaasto, P., K. Klingel, A. M. Lindberg, et al. 2004. Enterovirus infection in human pancreatic islet cells, islet tropism in vivo and receptor involvement in cultured islet beta cells. Diabetologia 47: 225-239. (Pubitemid 38315359)
31. Schulte, B. M., J. Bakkers, K. H. Lanke, et al. 2010. Detection of enterovirus RNA in peripheral blood mononuclear cells of type 1 diabetic patients beyond the stage of acute infection. Viral Immunol. 23: 99-104.
32. Gamble, D. R., M. L. Kinsley, M. G. FitzGerald, et al. 1969. Viral antibodies in diabetes mellitus. Br. Med. J. 3:627-630.
33. Richardson, S. J., A. Willcox, A. J. Bone, et al. 2009. The prevalence of enteroviral capsid protein vp1 immunostaining in pancreatic islets in human type 1 diabetes. Diabetologia 52: 1143-1151.
34. Dotta, F., S. Censini, A. G. van Halteren, et al. 2007. Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recentonset type 1 diabetic patients. Proc. Natl. Acad. Sci. USA 104: 5115-5120. (Pubitemid 47186185)
35. Shigemoto, T., M. Kageyama, R. Hirai, et al. 2009. Identification of loss of function mutations in human genes encoding RIG-I and MDA5: implications for resistance to type I diabetes. J. Biol. Chem. 284:13348-13354.
36. Downes, K., M. Pekalski, K. L. Angus, et al. 2010. Reduced expression of IFIH1 is protective for type 1 diabetes. PLoS One 5: e12646.
37. Chistiakov, D. A., N. V. Voronova, K. V. Savost'Anov, and R. I. Turakulov. 2010. Loss-of-function mutations E6 27X and I923V of IFIH1 are associated with lower poly(I:C)-induced interferon-beta production in peripheral blood mononuclear cells of type 1 diabetes patients. Hum. Immunol. 71:1128-1134.
38. Zouk, H., L. Marchand, and C. Polychronakos. 2010. Study of transcriptional effects in Cis at the IFIH1 locus. PLoS One 5: e11564.
39. Dixon, A. L., L. Liang, M. F. Moffatt, et al. 2007. A genome-wide association study of global gene expression. Nat. Genet. 39: 1202-1207. (Pubitemid 47482680)
40. Robinson, T., S. N. Kariuki, B. S. Franek, et al. 2011. Autoimmune disease risk variant of IFIH1 is associated with increased sensitivity to IFN-alpha and serologic autoimmunity in lupus patients. J. Immunol. 187:1298-1303.
41. The International HapMap Consortium. 2003. The International HapMap Project. Nature 426:789-796.
42. Kato, H., O. Takeuchi, E. Mikamo-Satoh, et al. 2008. Lengthdependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiationassociated gene 5. J. Exp. Med. 205:1601-1610. (Pubitemid 351962024)
43. Takahasi, K., M. Yoneyama, T. Nishihori, et al. 2008. Nonself RNA-sensing mechanism of RIG-I helicase and activation of antiviral immune responses. Mol. Cell 29:428-440.
44. The 1000 Genomes Project Consortium. 2010. A map of human genome variation from population-scale sequencing. Nature 467: 1061-1073.
45. Nam, H. Y., S. M. Shim, B. G. Han, and J. P. Jeon. 2011. Human lymphoblastoid cell lines: a goldmine for the biobankomics era. Pharmacogenomics 12: 907-917.
46. Shukla, S. J., and M. E. Dolan. 2005. Use of CEPH and non-CEPH lymphoblast cell lines in pharmacogenetic studies. Pharmacogenomics 6: 303-310. (Pubitemid 40601633)
47. Fumagalli, M., R. Cagliani, S. Riva, et al. 2010. Population genetics of IFIH1: ancient population structure, local selection, and implications for susceptibility to type 1 diabetes. Mol. Biol. Evol. 27:2555-2566.